Associazione Italiana Ematologia Oncologia Pediatrica
11
5
6
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Observational Study in Localized Osteosarcoma
Role: collaborator
Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )
Role: lead
Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)
Role: lead
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Role: lead
Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)
Role: lead
Validation of the GMFM-88 Scale and of the FAAP-O Scale in Pediatric Patients Affected by Cancer
Role: lead
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
Role: collaborator
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
Role: collaborator
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Role: lead
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Role: lead
Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
Role: collaborator
All 11 trials loaded